Austria-based Innerspace offers a VR simulation training platform for pharmaceutical companies to train and assess cleanroom personnel. Simulations are segmented by proficiency levels, with basic simulations focusing on reducing contamination risk and ensuring product safety. The advanced simulation modules comprise aseptic filling (environmental monitoring, exchanging settle plates, etc.) and biosafety cabinet modules (first air in biosafety cabinets, pipetting techniques, etc.).
The platform uses its proprietary “Frame-by-Frame” risk profiling technique for risk assessment of cleanroom personnel. It provides audiovisual feedback and an analytics dashboard and offers integration into an enterprise's Learning Management System (LMS).
Key customers and partnerships
Notable enterprises using the platform include Takeda, Ferring Pharmaceuticals, and IDT Biologika.
In June 2023, the company partnered with the Parenteral Drug Association (PDA) to integrate its frame-by-frame risk profiling capabilities into the PDA’s training courses for professionals in the pharmaceutical industry.
Funding and financials
In February 2024, the company raised EUR 5.7 million (~USD 6.1 million) in a funding round led by Matterwave Ventures. The funds were earmarked to expand its international presence and further develop its “Frame-by-Frame” technology.
Key competitors: None comparable (Innerspace focuses on VR training simulations specifically for cleanroom personnel in the pharmaceutical industry).
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.